Global and United States Vitamin K Antagonists (VKA) Market Report & Forecast 2022-2028

Global and United States Vitamin K Antagonists (VKA) Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Vitamin K Antagonists (VKA) Product Introduction
1.2 Global Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028
1.3 United States Vitamin K Antagonists (VKA) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Vitamin K Antagonists (VKA) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume for the Year 2017-2028
1.4 Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Vitamin K Antagonists (VKA) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Vitamin K Antagonists (VKA) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Vitamin K Antagonists (VKA) Market Dynamics
1.5.1 Vitamin K Antagonists (VKA) Industry Trends
1.5.2 Vitamin K Antagonists (VKA) Market Drivers
1.5.3 Vitamin K Antagonists (VKA) Market Challenges
1.5.4 Vitamin K Antagonists (VKA) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Vitamin K Antagonists (VKA) Market Segment by Type
2.1.1 Oral Vitamin K Antagonists
2.1.2 Injection Vitamin K Antagonists
2.2 Global Vitamin K Antagonists (VKA) Market Size by Type
2.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Vitamin K Antagonists (VKA) Market Size by Type
2.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Vitamin K Antagonists (VKA) Market Segment by Application
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Vitamin K Antagonists (VKA) Market Size by Application
3.2.1 Global Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Vitamin K Antagonists (VKA) Market Size by Application
3.3.1 United States Vitamin K Antagonists (VKA) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Vitamin K Antagonists (VKA) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Vitamin K Antagonists (VKA) Competitor Landscape by Company
4.1 Global Vitamin K Antagonists (VKA) Market Size by Company
4.1.1 Top Global Vitamin K Antagonists (VKA) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturer (2017-2022)
4.1.3 Global Vitamin K Antagonists (VKA) Sales by Manufacturer (2017-2022)
4.1.4 Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022)
4.2 Global Vitamin K Antagonists (VKA) Concentration Ratio (CR)
4.2.1 Vitamin K Antagonists (VKA) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vitamin K Antagonists (VKA) in 2021
4.2.3 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Type
4.3.1 Global Vitamin K Antagonists (VKA) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
4.3.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Vitamin K Antagonists (VKA) Market Size by Company
4.5.1 Top Vitamin K Antagonists (VKA) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Vitamin K Antagonists (VKA) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Vitamin K Antagonists (VKA) Sales by Players (2020, 2021 & 2022)
5 Global Vitamin K Antagonists (VKA) Market Size by Region
5.1 Global Vitamin K Antagonists (VKA) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Vitamin K Antagonists (VKA) Market Size in Volume by Region (2017-2028)
5.2.1 Global Vitamin K Antagonists (VKA) Sales in Volume by Region: 2017-2022
5.2.2 Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Vitamin K Antagonists (VKA) Market Size in Value by Region (2017-2028)
5.3.1 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2017-2022
5.3.2 Global Vitamin K Antagonists (VKA) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.1.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.3.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.4.2 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
7.1.5 Sanofi Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporation Information
7.2.2 Bristol-Myers Squibb Description and Business Overview
7.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Bayer
7.3.1 Bayer Corporation Information
7.3.2 Bayer Description and Business Overview
7.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
7.3.5 Bayer Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Genentech (Roche)
7.5.1 Genentech (Roche) Corporation Information
7.5.2 Genentech (Roche) Description and Business Overview
7.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
7.5.5 Genentech (Roche) Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporation Information
7.6.2 Boehringer Ingelheim Description and Business Overview
7.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
7.6.5 Boehringer Ingelheim Recent Development
7.7 Lilly
7.7.1 Lilly Corporation Information
7.7.2 Lilly Description and Business Overview
7.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
7.7.5 Lilly Recent Development
7.8 Daiichi Sankyo
7.8.1 Daiichi Sankyo Corporation Information
7.8.2 Daiichi Sankyo Description and Business Overview
7.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
7.8.5 Daiichi Sankyo Recent Development
7.9 Otsuka
7.9.1 Otsuka Corporation Information
7.9.2 Otsuka Description and Business Overview
7.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
7.9.5 Otsuka Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Corporation Information
7.10.2 AstraZeneca Description and Business Overview
7.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Pfizer
7.11.1 Pfizer Corporation Information
7.11.2 Pfizer Description and Business Overview
7.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Pfizer Vitamin K Antagonists (VKA) Products Offered
7.11.5 Pfizer Recent Development
7.12 Aspen
7.12.1 Aspen Corporation Information
7.12.2 Aspen Description and Business Overview
7.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Aspen Products Offered
7.12.5 Aspen Recent Development
7.13 The Medicines Company
7.13.1 The Medicines Company Corporation Information
7.13.2 The Medicines Company Description and Business Overview
7.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2017-2022)
7.13.4 The Medicines Company Products Offered
7.13.5 The Medicines Company Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
8.2 Vitamin K Antagonists (VKA) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Vitamin K Antagonists (VKA) Distributors
8.3 Vitamin K Antagonists (VKA) Production Mode & Process
8.4 Vitamin K Antagonists (VKA) Sales and Marketing
8.4.1 Vitamin K Antagonists (VKA) Sales Channels
8.4.2 Vitamin K Antagonists (VKA) Distributors
8.5 Vitamin K Antagonists (VKA) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Vitamin K Antagonists (VKA) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Vitamin K Antagonists (VKA) Market Trends
Table 3. Vitamin K Antagonists (VKA) Market Drivers
Table 4. Vitamin K Antagonists (VKA) Market Challenges
Table 5. Vitamin K Antagonists (VKA) Market Restraints
Table 6. Global Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Vitamin K Antagonists (VKA) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Vitamin K Antagonists (VKA) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Vitamin K Antagonists (VKA) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Vitamin K Antagonists (VKA) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Vitamin K Antagonists (VKA) Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturer, 2017-2022
Table 15. Global Vitamin K Antagonists (VKA) Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2021)
Table 18. Top Players of Vitamin K Antagonists (VKA) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Vitamin K Antagonists (VKA) Product Type
Table 20. Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Vitamin K Antagonists (VKA) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Vitamin K Antagonists (VKA) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Vitamin K Antagonists (VKA) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Vitamin K Antagonists (VKA) Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Vitamin K Antagonists (VKA) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Vitamin K Antagonists (VKA) Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Vitamin K Antagonists (VKA) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Vitamin K Antagonists (VKA) Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Vitamin K Antagonists (VKA) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Vitamin K Antagonists (VKA) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Sanofi Vitamin K Antagonists (VKA) Product
Table 46. Sanofi Recent Development
Table 47. Bristol-Myers Squibb Corporation Information
Table 48. Bristol-Myers Squibb Description and Business Overview
Table 49. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Bristol-Myers Squibb Product
Table 51. Bristol-Myers Squibb Recent Development
Table 52. Bayer Corporation Information
Table 53. Bayer Description and Business Overview
Table 54. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Bayer Product
Table 56. Bayer Recent Development
Table 57. Johnson & Johnson Corporation Information
Table 58. Johnson & Johnson Description and Business Overview
Table 59. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Johnson & Johnson Product
Table 61. Johnson & Johnson Recent Development
Table 62. Genentech (Roche) Corporation Information
Table 63. Genentech (Roche) Description and Business Overview
Table 64. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Genentech (Roche) Product
Table 66. Genentech (Roche) Recent Development
Table 67. Boehringer Ingelheim Corporation Information
Table 68. Boehringer Ingelheim Description and Business Overview
Table 69. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Boehringer Ingelheim Product
Table 71. Boehringer Ingelheim Recent Development
Table 72. Lilly Corporation Information
Table 73. Lilly Description and Business Overview
Table 74. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Lilly Product
Table 76. Lilly Recent Development
Table 77. Daiichi Sankyo Corporation Information
Table 78. Daiichi Sankyo Description and Business Overview
Table 79. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Daiichi Sankyo Product
Table 81. Daiichi Sankyo Recent Development
Table 82. Otsuka Corporation Information
Table 83. Otsuka Description and Business Overview
Table 84. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Otsuka Product
Table 86. Otsuka Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Business Overview
Table 94. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Aspen Corporation Information
Table 98. Aspen Description and Business Overview
Table 99. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Aspen Product
Table 101. Aspen Recent Development
Table 102. The Medicines Company Corporation Information
Table 103. The Medicines Company Description and Business Overview
Table 104. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. The Medicines Company Product
Table 106. The Medicines Company Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Vitamin K Antagonists (VKA) Customers List
Table 110. Vitamin K Antagonists (VKA) Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin K Antagonists (VKA) Product Picture
Figure 2. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million)
Figure 4. Global Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT)
Figure 5. United States Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Vitamin K Antagonists (VKA) Market Size 2017-2028 (US$ Million)
Figure 7. United States Vitamin K Antagonists (VKA) Sales 2017-2028 (K MT)
Figure 8. United States Vitamin K Antagonists (VKA) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Vitamin K Antagonists (VKA) Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Vitamin K Antagonists (VKA) Report Years Considered
Figure 11. Product Picture of Oral Vitamin K Antagonists
Figure 12. Product Picture of Injection Vitamin K Antagonists
Figure 13. Global Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028
Figure 14. Global Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT)
Figure 17. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Vitamin K Antagonists (VKA) Market Share by Type in 2022 & 2028
Figure 20. United States Vitamin K Antagonists (VKA) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Vitamin K Antagonists (VKA) Sales by Type (2017-2028) & (K MT)
Figure 23. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Vitamin K Antagonists (VKA) Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of VTE
Figure 26. Product Picture of ACS/MI
Figure 27. Product Picture of AF
Figure 28. Product Picture of Others
Figure 29. Global Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028
Figure 30. Global Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT)
Figure 33. Global Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Vitamin K Antagonists (VKA) Market Share by Application in 2022 & 2028
Figure 36. United States Vitamin K Antagonists (VKA) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Vitamin K Antagonists (VKA) Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Vitamin K Antagonists (VKA) Sales by Application (2017-2028) & (K MT)
Figure 39. United States Vitamin K Antagonists (VKA) Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Vitamin K Antagonists (VKA) Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Vitamin K Antagonists (VKA) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Vitamin K Antagonists (VKA) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Vitamin K Antagonists (VKA) Value Chain
Figure 75. Vitamin K Antagonists (VKA) Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs